Diabetes Discharge Transitional CGM Study (DDT-CGM)
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 120 participants.
Also called NCT04729985
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 120 participants
- Registry
-
NCT04729985
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04729985. Randomized; single masking; primary purpose prevention. Start 2021-06-01 (actual); primary completion 2024-07-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Diabetes Discharge Transitional CGM Study (DDT-CGM)
- Acronym
- DDT-CGM
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Device)
- CGM device with diabetic education, CGM education and a follow up protocol.
- Lead sponsor
- Intermountain Health Care, Inc.
- Collaborator
- Abbott
Record details
- Record id
cardio:ct-nct04729985- Content hash
96094805ab5f0e26629b2f99779be53cf242f611699166d0fec0bc1f8456776e